Search

Search

Log in or registerMenuClose

Search

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

Legal 500 Trust Centre
Contact Us

Market Intelligence
Search

Your search for ‘Goodwin Procter LLP’ returned 4,550 results

Use advanced search filters to refine your search

Search

Advanced search filters

Topics

Search for topics

Countries

Search for countries

Contributor

Search to show contributors

Start typing to add contributors

Content type

Any
Article
Podcast
Video

Sort by

Article
Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India
As reported by HealthCareRadius in India, on February 23, 2023, Enzene Biosciences, a subsidiary of Alkem Laboratories, announced commencement of commercial supplies of its biosimilar adalimumab (ENZ-129)...
GlobalFood, Drugs, Healthcare, Life Sciences
Goodwin Procter LLP
Article
Celltrion's CT-P6 Demonstrates Equivalent Safety, Efficacy With HERCEPTIN
A recently-published study reported that Celltrion's CT-P6 (HERZUMA, trastuzumab-pkrb) demonstrated equivalent safety and efficacy compared with...
GlobalFood, Drugs, Healthcare, Life Sciences
Goodwin Procter LLP

China NMPA Approves TYVYT (sintilimab) In Combination With Chemotherapy For Gastric Cancer

On June 24, 2022, Innovent Biologics, Inc. and Eli Lilly and Company announced that the National Medical Products Administration (NMPA) of China approved the supplemental New Drug Application (sNDA) for...

GlobalFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

COSO Withdraws Proposed Corporate Governance Framework

On July 16, 2025, the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") announced the withdrawal of its draft Corporate Governance Framework ("CGF").

United StatesCorporate/Commercial Law

Goodwin Procter LLP

New Directions Audio Series

As the Trump Administration approaches 100 days in office, we explore the key policy shifts and regulatory changes affecting business and markets across industries in our New Directions Audio Series.

United StatesCorporate/Commercial Law

Goodwin Procter LLP

Paul Atkins Confirmed As SEC Chairman

Paul Atkins was confirmed as the Chairman of the SEC on Wednesday by a vote of 52-44. He will serve during the remainder of former Chair Gary Gensler's term...

United StatesCorporate/Commercial Law

Goodwin Procter LLP

Featured Speaker: State Of The Real Estate Capital Markets, REIT, Private And IPO Market (Video)

Roy March, Chief Executive Officer, Eastdil Secured

United StatesFinance and Banking

Goodwin Procter LLP

Tech Start-Ups Face Dilemma Over Expiring Staff Share Awards (Financial Times)

Tech start-ups that have delayed plans to go public during an industry downturn are facing a new dilemma.

United StatesFinance and Banking

Goodwin Procter LLP

A Look Ahead In Life Sciences: What We Are Tracking In Q2 2024 And Beyond

As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, and compliance landscape.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

A Look Ahead In Life Sciences: What We Are Tracking In Q3 2023 And Beyond

As the life sciences industry continues to expand and grow increasingly complex, so does its legal, regulatory, and compliance landscape.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

AbbVie And Novartis Announce Billion Dollar Licensing Deals For Oncology And Alzheimer's Treatments

On January 12, 2026, AbbVie and RemeGen announced an exclusive licensing agreement granting AbbVie rights to develop, manufacture, and commercialize RemeGen's RC148 outside of Greater China.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

Alteogen Seeks Approval For Aflibercept Biosimilar In Korea

On September 13, 2024, Alteogen announced that it has applied for marketing authorization in Korea for ALT-L9, an aflibercept biosimilar of EYLEA®.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

Bio-Thera And Intas Expand Golimumab Biosimilar Partnership To India

On March 23, 2026, Bio-Thera Solutions announced an expansion of its existing partnership with Intas Pharmaceuticals for BAT2506, its golimumab biosimilar...

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

Biogen Seeks Preliminary Injunction In Natilizumab BPCIA Litigation – Hearing Scheduled For May 17

The parties completed their briefing on Biogen's motion in April, and Judge Williams has scheduled a hearing for May 17 at 1 pm EST.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

California's Governor Newsom Announces That State Sponsored Insulin Pen Will Be Available Jan 1, 2026

On October 17, Governor Newsom announced that California will be launching the "first and only" state contracted affordable insulin.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

Celltrion Announces Phase III Results For Aflibercept Biosimilar

On April 3, 2023, Celltrion announced positive 24-week results from its global Phase III Clinical Trial of CT-P42, a biosimilar referencing Regeneron's EYLEA.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

Celltrion Launches STEQEYMA® (ustekinumab-stba) In The United States

On March 12, 2025, Celltrion announced the commercial launch of STEQEYMA® (ustekinumab-stba), a biosimilar of Janssen's STELARA® (ustekinumab), in the United States.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

CuraTeQ Biologics' Trastuzumab Biosimilar Receives Positive Opinion In Europe

This week, CuraTeQ Biologics (a wholly owned step-down subsidiary of Aurobindo Pharma Limited) announced that its trastuzumab biosimilar...

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

EMA Accepts MAA For Dong-A ST's Ustekinumab Biosimilar

On July 14, Dong-A ST announced that the European Medicines Agency accepted its Marketing Authorization Application for DMB-3115, a biosimilar referencing STELARA.

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

EMA Accepts Marketing Authorization Application For Alvotech's AVT05 (Golimumab)

On November 4, 2024, Alvotech and Advanz Pharma announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Application for AVT05...

United StatesFood, Drugs, Healthcare, Life Sciences

Goodwin Procter LLP

Showing 121–140 of 4550 results

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics